Misappropriation Found, $0 in Damages: Applied Medical Distribution Corp. v. Jarrells
Executive Summary
A jury found that a departing executive and his new employer both misappropriated their former employer’s trade secrets—and awarded the former employer nothing. That split outcome, and the years of post-trial and appellate litigation that followed it, is what makes Applied Medical Distribution Corp. v. Jarrells worth attention. The published opinion offers practical guidance on what a trade secret plaintiff can recover when the jury awards no damages, and on how courts apportion contractual fees when a party prevails on some claims and not others.
| Claim / Stage | Outcome |
|---|---|
| Trade secret misappropriation (CUTSA) — Jarrells | Liability found; no damages; no unjust enrichment |
| Trade secret misappropriation (CUTSA) — Bruin | Liability found; no damages; no unjust enrichment |
| Breach of proprietary information agreement (Jarrells) | Breach found; no harm |
| Breach of fiduciary duty (Jarrells) | Defense verdict |
| Intentional interference with contract (Bruin) | Defense verdict |
| Jury damages awarded | $0 on all claims |
| Post-trial relief (trial court) | Permanent injunction; ~$554,000 fees/costs (of ~$3.9M requested) |
| Disposition on appeal | Affirmed in part, reversed in part, remanded |
Case Information
Case Caption: Applied Medical Distribution Corp. v. Jarrells
Court: California Court of Appeal, Fourth Appellate District, Division Three
Case Number: G062056 (certified for publication)
Trial Court: Superior Court of Orange County, Case No. 30-2019-01049441 (Hon. Robert J. Moss and Hon. Michael J. Strickroth)
Opinion Filed: March 8, 2024
Disposition: Affirmed in part, reversed in part, and remanded
Matter: Trade secret misappropriation under the California Uniform Trade Secrets Act (CUTSA), with related claims for breach of a proprietary information agreement, breach of fiduciary duty, and intentional interference with contract.
Parties
Plaintiff: Applied Medical Distribution Corporation, a company that sells and distributes medical devices manufactured by its parent, Applied Medical Resources.
Defendant (Jarrells): Stephen Jarrells, a former Applied vice president who left to join a competitor. During his tenure he was promoted several times, ultimately to a vice president overseeing group purchasing organizations.
Defendant (Bruin): Bruin Biometrics, LLC, the competing medical device company Jarrells joined as vice president of sales. Applied dismissed Bruin without prejudice before judgment.
Counsel
Plaintiff’s Counsel: Jones Day — Nathaniel P. Garrett, Koree B. Wooley, David A. Phillips, and Steven M. Zadravecz.
Counsel for Defendant Jarrells: Forward Counsel — Michael E. Caspino and Michael W. Weiler.
Key Findings
• Liability without damages. The jury found that both Jarrells and Bruin acquired, used, or disclosed Applied’s trade secrets by improper means, but that the misappropriation was not a substantial factor in causing Applied damage or in unjustly enriching either defendant.
• Breach without harm. The jury found Jarrells breached his proprietary information agreement, but that Applied was not harmed by the breach.
• Defense verdicts on the remaining claims. The jury found no breach of fiduciary duty by Jarrells and no intentional interference by Bruin.
• Zero-dollar verdict. The jury awarded no damages on any claim.
• Equitable and contractual relief. The trial court granted a permanent injunction under both CUTSA and the agreement, and awarded roughly $554,000 in fees and costs against a request of approximately $3.9 million.
• On appeal. The Court of Appeal affirmed Applied’s status as prevailing party and its entitlement to the injunction and contractual fees, but reversed the fee calculation and the exclusion of certain mitigation costs, and reversed a nonsuit on willful and malicious misappropriation—remanding that issue for a new jury trial.
Factual Background
Employment and the Agreement
Stephen Jarrells joined Applied Medical in 2011 and was promoted repeatedly over the next several years—first to district sales manager, then to director of corporate accounts, director of advanced energy education, and finally to a vice president overseeing group purchasing organizations. When he was hired, he signed a proprietary information agreement requiring him to hold Applied’s confidential information in strict confidence, to return all company materials on departure. At that time, he acknowledging that breaches would be difficult to quantify and could be addressed through injunctive relief with the employee responsible for the reasonable fees and costs incurred to obtain that relief.
The “Good Stuff” Folder
According to the court’s recitation of the record, in December 2018 Jarrells accepted a position as vice president of sales at Bruin Biometrics, a competing medical device manufacturer. Before resigning in January 2019, he created a folder on his Applied laptop titled “Good Stuff,” copied Applied trade secrets and confidential information into it, transferred the contents to a thumb drive, and uploaded them to a computer issued by Bruin. He then wiped his Applied computer and network drives and returned the device. The court noted Jarrells acknowledged he knew his actions violated the agreement and did not tell Applied because in his words, he “did not want the company to know what [he] had done.”
Suit and Stipulated Injunction
After noticing an unusual volume of downloads and data transfers, Applied retained an outside forensic expert and sued the month after Jarrells left. Jarrells and Bruin contested the claims. The parties stipulated to a preliminary injunction that expressly disclaimed any admission of wrongdoing and could not be used to establish a prevailing party. Applied later amended its complaint to add a breach of fiduciary duty claim against Jarrells and claims for misappropriation and intentional interference against Bruin.
Verdict, Injunction, and Fees
At trial, the jury found misappropriation by both defendants but awarded no damages, and returned defense verdicts on the fiduciary duty and interference claims. The trial court then granted Applied a permanent injunction resting on both CUTSA and the agreement. Applied sought roughly $3.9 million in combined fees and costs under the agreement’s fee provision; the court awarded approximately $554,000, reducing the fee request to about 25 percent on the reasoning that Applied had prevailed on only one of four claims, and declining to award fees for discovery and motion practice. Both sides appealed.
Analysis
A misappropriation finding is not a damages award. The central lesson is structural: liability and damages are separate questions, and a jury can resolve the first for the plaintiff and the second for the defense. Causation and damages in trade secret cases often turn on proof that is difficult to quantify—particularly where, as here, there is little evidence that the information was actually used to the plaintiff’s detriment or to the defendant’s gain. The same record can support both a clear finding that secrets were taken and a determination that the taking caused no measurable loss.
In a no-damages case, the real remedy is the injunction and contractual fees. When the jury awards nothing, the meaningful relief shifts to equity and contract. Here, the injunction and the agreement’s fee-shifting provision not the verdict became the operative remedies. The decision confirms that a plaintiff who secures injunctive relief can be the prevailing party entitled to contractual fees even without a damages recovery, which underscores the practical value of well-drafted equitable-relief and fee provisions in proprietary information agreements.
The opinion draws a line on which litigation costs count as damages. The court held that a misappropriation plaintiff may recover the expert fees incurred to stop or mitigate misappropriation, but not the fees incurred merely to investigate a suspected misappropriation. Because Applied had offered evidence its forensic expert performed mitigation work, excluding those fees from the damages presented to the jury was error. The distinction will shape how parties characterize and document their forensic work.
Fee awards cannot be apportioned mechanically. The reversal on fees is a caution against simple math. A court may not award a percentage tied only to the number of claims won; it must consider whether the unsuccessful claims were factually intertwined with the successful one, and it may not categorically exclude entire categories of work such as discovery and motion practice from a contractual fee award.
A favorable damages verdict did not end the financial risk. The court reversed a nonsuit on whether the misappropriation was willful and malicious, finding evidence from which a reasonable jury could so conclude, and remanded that question for a new trial. A willfulness finding could support attorney fees under Civil Code section 3426.4 and the court’s consideration of exemplary damages, so the defense’s zero-dollar result at trial is not necessarily the last word on exposure.
The cost and duration of a “win” cut both ways. Both sides invested years in a dispute that produced a zero-dollar verdict and then continued through post-trial motions, an appeal, and a remand for a second trial with fees alone as the subject of a multimillion-dollar request. Whatever the eventual outcome on remand, the case illustrates how much time, expense, and uncertainty can remain on both sides of the table even after a jury has spoken.
Documents
Opinion, Applied Medical Distribution Corp. v. Jarrells, No. G062056 (Cal. Ct. App. Mar. 8, 2024)